Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease
During the last century, there has been an increasing prevalence of hyperuricaemia noted in
many populations. While uric acid is usually discussed in the context of gout …
many populations. While uric acid is usually discussed in the context of gout …
Physiology of hyperuricemia and urate-lowering treatments
CL Benn, P Dua, R Gurrell, P Loudon, A Pike… - Frontiers in …, 2018 - frontiersin.org
Gout is the most common form of inflammatory arthritis and is a multifactorial disease
typically characterized by hyperuricemia and monosodium urate crystal deposition …
typically characterized by hyperuricemia and monosodium urate crystal deposition …
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels
Elevated serum urate levels cause gout and correlate with cardiometabolic diseases via
poorly understood mechanisms. We performed a trans-ancestry genome-wide association …
poorly understood mechanisms. We performed a trans-ancestry genome-wide association …
Коморбидная патология в клинической практике. Клинические рекомендации
РГ Оганов, ИН Денисов, В Симаненков… - Кардиоваскулярная …, 2017 - cyberleninka.ru
Рабочая группа: академик РАН, профессор РГ Оганов (Председатель)(Москва),
академик РАН, профессор ИН Денисов (Председатель)(Москва), профессор ВИ …
академик РАН, профессор ИН Денисов (Председатель)(Москва), профессор ВИ …
Asymptomatic hyperuricaemia: a silent activator of the innate immune system
Asymptomatic hyperuricaemia affects~ 20% of the general population in the USA, with
variable rates in other countries. Historically, asymptomatic hyperuricaemia was considered …
variable rates in other countries. Historically, asymptomatic hyperuricaemia was considered …
Uric acid and the cardio‐renal effects of SGLT2 inhibitors
CJ Bailey - Diabetes, Obesity and Metabolism, 2019 - Wiley Online Library
Sodium/glucose co‐transporter‐2 (SGLT2) inhibitors, which lower blood glucose by
increasing renal glucose elimination, have been shown to reduce the risk of adverse …
increasing renal glucose elimination, have been shown to reduce the risk of adverse …
Urate, blood pressure, and cardiovascular disease: evidence from mendelian randomization and meta-analysis of clinical trials
Serum urate has been implicated in hypertension and cardiovascular disease, but it is not
known whether it is exerting a causal effect. To investigate this, we performed Mendelian …
known whether it is exerting a causal effect. To investigate this, we performed Mendelian …
Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
M Bredemeier, LM Lopes, MA Eisenreich… - BMC cardiovascular …, 2018 - Springer
Background Xanthine oxidase inhibitors (XOI), classified as purine-like (allopurinol and
oxypurinol) and non-purine (febuxostat and topiroxostat) XOI, present antioxidant properties …
oxypurinol) and non-purine (febuxostat and topiroxostat) XOI, present antioxidant properties …
Asymptomatic hyperuricemia: is it really asymptomatic?
K Yip, RE Cohen, MH Pillinger - Current opinion in rheumatology, 2020 - journals.lww.com
Accumulating evidence suggests that asymptomatic hyperuricemia contributes to the
comorbidities with which it associates and that proper asymptomatic hyperuricemia …
comorbidities with which it associates and that proper asymptomatic hyperuricemia …
Hyperuricemia and progression of chronic kidney disease: a review from physiology and pathogenesis to the role of urate-lowering therapy
The relationship between hyperuricemia, gout, and renal disease has been investigated for
several years. From the beginning, kidney disease has been considered a complication of …
several years. From the beginning, kidney disease has been considered a complication of …